Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 28;12(2):204-206.
doi: 10.21037/tlcr-22-888. Epub 2023 Jan 15.

Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy?

Georg Schlachtenberger  1 , Khosro Hekmat  1 , Thorsten Wahlers  1 , Matthias B Heldwein  1
Affiliations
Editorial

Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy?

Georg Schlachtenberger et al. Transl Lung Cancer Res. .
No abstract available

Keywords: Lung cancer; adjuvant chemotherapy (AC); locally advanced non-small cell lung cancer (locally advanced NSCLC).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-22-888/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28:iv1-iv21. 10.1093/annonc/mdx222 - DOI - PubMed
    1. Wang X, Guo H, Hu Q, et al. The Impact of Skip vs. Non-Skip N2 Lymph Node Metastasis on the Prognosis of Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Front Surg 2021;8:749156. 10.3389/fsurg.2021.749156 - DOI - PMC - PubMed
    1. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006;7:719-27. 10.1016/S1470-2045(06)70804-X - DOI - PubMed
    1. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-97. 10.1056/NEJMoa043623 - DOI - PubMed
    1. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-60. 10.1056/NEJMoa031644 - DOI - PubMed